Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher Scientific Expanded Invitrogen TrueEdit Tool Kit

Thermo Fisher Scientific has expanded its Invitrogen TrueEdit tool kit. The portfolio now includes the Invitrogen TrueCut Cas9 Protein v2, a recombinant Streptococcus pyogenes Cas9 protein for genome editing with CRISPR technology. This CRISPR-Cas9 protein is designed to deliver consistently high editing efficiency in all cell lines including standard, immune, primary, and stem. In addition, the firm's new product line of ready-to-transfect Invitrogen TrueGuide Synthetic gRNAs offers researchers a range of selections, from economical options for routine editing tasks to high-performance choices for editing in challenging cell types such as primary cells, immune cells, and stem cells. Thermo Fisher also offers predesigned synthetic gRNAs for the entire human and mouse genome, selected for maximum knockout efficiency and specificity.
The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.